EMA recommends approval of Imvanex for the prevention of monkeypox disease

EMA

22 July 2022 - The EMA’s has recommended extending the indication of the smallpox vaccine Imvanex to include protecting adults from monkeypox disease.

The vaccine has been approved in the EU since 2013 for the prevention of smallpox

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Europe , Vaccine